Team:BIOSINT Mexico/pitch

From 2012e.igem.org

(Difference between revisions)
 
Line 148: Line 148:
<div class="wrap top-9">
<div class="wrap top-9">
                     <div class="p-border">
                     <div class="p-border">
-
                             <div class="wrap">
+
                             <div class="wrap"></br></br>
                                 <p class="clr-1"><strong>Executive summary.</strong></p>
                                 <p class="clr-1"><strong>Executive summary.</strong></p>
                             </div>
                             </div>
Line 168: Line 168:
<div class="wrap top-9">
<div class="wrap top-9">
                     <div class="p-border">
                     <div class="p-border">
-
                             <div class="wrap">
+
                             <div class="wrap"></br></br>
                                 <p class="clr-1"><strong>Source data.</strong></p>
                                 <p class="clr-1"><strong>Source data.</strong></p>
                             </div>
                             </div>

Latest revision as of 04:53, 28 October 2012

Kuxtal

WHAT I CANNOT CREATE, I DO NOT UNDERSTAND RICHARD FEYNMAN’S
Mexico is located in the “Ring of Fire”.
It is one of the earth’s most violent earthquake and volcano zones.

Project Summary

Elevator pitch video.



Business model.



Executive summary.

Continuous advances in biological science have led to the broadening of commercially available molecular biology reagents and equipment, from where many techniques, applications, products and services for both industry and laboratory have developed.

Latin America is a region with great potential in market development and expansion.



Consolidating a Synthetic Biology enterprise that provides custom synthetically designed and optimized genes, recombinant proteins, and specialized biotechnological solutions in the region, would capture the existing market-share and at the same time would fuel the development of a fresh new market that currently remains underexploited.


Regional Average 57.2/ Global Average 53.8/ Emerging Markets Average 51.3
Source: BMI 2012



Kuxtal Biotech has identified the need for a company that supplies quality services with both speed and an excelling customer support. The opportunities for business development of genomic technologies in Mexico have been underrated. Kuxtal Biotech intends to get a grip on the already existing market, and develop it, by supplying quality products and services with on-time deliveries, validation, and technical assistance through all the research and project development process.



Source data.

Biotechnology, BBC Reports (2011). Synthetic Biology: Emerging Global Markets, Report Code:BIO066B. http://www.bccresearch.com/report/global-synthetic-biology-markets-bio066b.html

Booth, W., Miroff, N. (2012). Middle class is booming in a changing Mexico. The Washington Post. http://seattletimes.nwsource.com/avantgo/2017786810.html

CICESE (enero-marzo, 2001). Contrataciones en términos de la ley de adquisiciones, arrendamientos y servicios del sector público. Recovered on october 16th of 2012, of http://transparencia.cicese.mx/operaciones_reportables_1ertrimestre_2011.pdf

Czazr, MJ, Anderson, JC, Bader, JS, Peccoud, J. 2008, Gene synthesis demystified. Trends in Biotechnology 27(2):63-72.

El Economista (2012, november 24th). Lanzarán cluster de biotecnología en Querétaro. Retrieved on april 22nd of 2012, of http://eleconomista.com.mx/industrias/2010/11/24/lanzaran-cluster-biotecnologia

Fume Hoods Laboratories, 2005. Stanford Laboratory Standard & Design Guide, Version 2.0/ 12-05. Section 1.1 pp 1-24.

General Requirements for Stanford Laboratories, 2006. Stanford Laboratory Standard & Design Guide, Version 2.0/ 11-06. Section 1. pp 1-14

Grupo de Desarrollo Regional del Tecnológico de Monterrey (2009). Las megatendencias tecnológicas actuales y su impacto en la identificación de oportunidades estratégicas de negocios. México: ITESM. ISBN: 978-607-7517-94-8

iGEM (2011). Regional jamboree. Retrieved on April 22nd of 2012, of https://igem.org/Team_Wikis?year=2011

iGEM. Identidad campus Querétaro (http://identidad.campusqueretaro.net/?s=igem).

INEGI (2012). Producción científica y tecnológica. Recovered on october 16th of 2012, of http://www.inegi.org.mx/Sistemas/temasV2/Default.aspx?s=est&c=19007

ISO 9001:2008 http://www.iso.org/iso/catalogue_detail?csnumber=46486

ISO 14001:2004 http://www.iso.org/iso/catalogue_detail?csnumber=31807

Laboratory Design Handbook, TSI Incorporated, 500 Cardigan Road, Shoreview, MN 55126-3996 USA pp 1-36.

Laboratory Design & Construction Guidelines, 2010. University of Carolina. Document EHS-M-35 pp 1-11.

Moreno-Brid, J.C. y Ruiz-Nápoles, P. (2003). De La educación superior y el desarrollo económico en América Latina. UNESCO.

National Research Council (NRC), 2101 Constitution Avenue, NW, Washington, DC 20418, http://www.nas.edu

OHSAS 18001:2007 http://www.bsigroup.com/en/Assessment-and-certification-services/management-systems/at-a-glance/

Pérez-Hermosillo, J. E., & Leal-García, C. (2009). Identificación de oportunidades estratégicas para el desarrollo de la Región Querétaro-Celaya. México: ITESM. ISBN: 978-607-7517-45-0

Sistema de Información Empresarial Mexicano (2012). Estadísticas [database]. México. Recovered on october 7th of 2012, of http://www.siem.gob.mx/siem/portal/estadisticas/ActXedo.asp

Possani, L. D. (2003). The past, present, and future of biotechnology in Mexico. Nature Publishing Group , 852-853.

Pressure Vessels & Compressed Gas Cylinders, 2003. Stanford Laboratory Standard & Design Guide Version 2.0/ 10-03. Section 1.3, pp1-8.

Tecnológico de Monterrey. iTunesU (http://itunes.itesm.mx/).

2010 Global Synthetic Biology, Technology Surveillance Report, Asociación Mexicana de Biología Sintética, AC., 2010.

US Centers for Disease Control and Prevention (CDC), 1600 Clifton Road NE, Atlanta, GA 30333, http://www.cdc.gov/